VMI
SRRA

VHCP Management II’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

VHCP Management II’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,270
Closed -$153K – 23
2017
Q2 		$153K Hold
3,270
– – 0.06% 19
2017
Q1 		$200K Hold
3,270
– – 0.08% 20
2016
Q4 		$195K Hold
3,270
– – 0.09% 22
2016
Q3 		$238K Hold
3,270
– – 0.12% 24
2016
Q2 		$260K Hold
3,270
– – 0.16% 23
2016
Q1 		$882K Sell
3,270
-1,105
-25% -$353K 0.58% 22
2015
Q4 		$2.63M Buy
+4,375
New +$2.96M 2.16% 14

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

VHCP Management II's SRRA Position: Q3 2017 in Review

VHCP Management II sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2017, closing a stake of 3,270 shares — an estimated $153K sold.

VHCP Management II first reported a position in SRRA in Q4 2015 and held it in 7 quarters. The position peaked at $2.63M in Q4 2015. 41 funds tracked by Wall St. Rank hold SRRA as of Q3 2017.

  • VHCP Management II reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • VHCP Management II sold 3,270 Sierra Oncology, Inc. Common Stock shares in Q3 2017, an estimated $153K.
  • VHCP Management II first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 7 quarters.
  • VHCP Management II's Sierra Oncology, Inc. Common Stock position peaked at $2.63M in Q4 2015.
  • 41 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2017.

Based on VHCP Management II's 13F filing for Q3 2017, filed 13 Nov 2017.